SCHEMBL7459131

SCHEMBL7459131

CC(C)n1cc(CCN2CCC(c3c[nH]c4ccc(O)cc34)CC2)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
THPO P40225 1/20 0.56
MAPT P10636 1/20 0.49
BLM P54132 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HTR1B P28222 4/20 0.42
HTR2A P28223 4/20 0.42
HTR7 P34969 4/20 0.42
DRD2 P14416 3/20 0.42
HTR1A P08908 2/20 0.42
HTR2C P28335 1/20 0.42
HTR1E P28566 1/20 0.42
HTR1F P30939 1/20 0.42
DRD3 P35462 1/20 0.42
HTR2B P41595 1/20 0.42
CCR2 P41597 1/20 0.42
HTR6 P50406 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7463598 0.89 OPRM1 (0.52) HTR2AHTR7DRD2HTR1AHTR6
SCHEMBL7460288 0.89 OPRM1 (0.56) CYP1A2CYP3A4CYP2D6CYP2C9THPO
SCHEMBL7459744 0.87 SLC6A4 (0.54) HTR2AHTR7DRD2HTR1AHTR6
Oxalic Acid SCHEMBL9049243 0.86 HTR1D (0.49) HTR1BHTR2AHTR7DRD2HTR1A
Oxalic Acid SCHEMBL9048457 0.86 HTR1D (0.41) CYP1A2CYP3A4CYP2D6CYP2C9THPO
Hydrochloric Acid SCHEMBL9050891 0.86 ADRA1D (0.55) CYP2D6HTR2AHTR7DRD2SLC6A4
Oxalic Acid SCHEMBL9048375 0.85 MAPT (0.56) CYP1A2CYP3A4CYP2D6CYP2C9THPO
SCHEMBL7456066 0.85 CYP1A2 (0.56) CYP1A2CYP3A4CYP2D6CYP2C9THPO
Oxalic Acid SCHEMBL9046836 0.85 SLC6A4 (0.51) HTR2AHTR7DRD2HTR1ACCR2
SCHEMBL7460711 0.83 CYP1A2 (0.53) CYP1A2CYP3A4CYP2D6CYP2C9THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0708102-B1 5-HT1F agonists for the treatment of migraine LILLY CO ELI (US) 2002-12-11 EP disclosed
EP-0708102-A1 5-HT1F agonists for the treatment of migraine ELI LILLY AND COMPANY (US) 1996-04-24 EP disclosed